Skip to content
Parakho

Tatva Chintan Pharma Chem Ltd

NSE TATVABSE 543321tatvachintan.com

Q1 FY27, unaudited

Revenue
₹167.06 Cr
Profit after tax
₹15.98 Cr

As filed with the exchange, consolidated basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, consolidated basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations167.06+42.95%505.86
Other income2.78+140.69%3.55
Total income169.84+43.90%509.41
Employee benefit expense16.74+18.81%62.93
Finance costs2.08+403.87%2.85
Depreciation & amortisation10.57+17.78%36.85
Total expenses147.41+35.34%452.40
Profit before tax21.11+131.96%57.01
Tax expense5.13+109.39%14.96
Profit after tax15.98+140.28%42.05
Total comprehensive income15.66+115.70%45.27
Earnings per share
Earnings per share, basic₹6.83₹17.98
Earnings per share, diluted₹6.83₹17.98

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base — unaudited, from the company’s filing with NSE. Source

FY26 — unaudited, from the company’s filing with NSE. Source

Earnings call

Q1 FY27

Tatva Chintan reported Q1 FY27 operating revenue of INR1,671 million, up 43% year-on-year and 25% sequentially, with EBITDA of INR323 million, up 86% year-on-year. Management highlighted growth across Phase Transfer Catalysts, Pharma & Agro Intermediates, and Structure Directing Agents segments, along with the first commercial-scale semiconductor product batch being qualified by a customer. The Board approved a new greenfield manufacturing facility involving an investment of approximately INR200 crores.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary

Earlier calls: Q4 FY26 · All quarters

Filings

12 shown · 40 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 19 Aug 2026.